Related Experiment Videos

Reduced calcium dialysis fluids: what's the point?

A J Hutchison, R Gokal

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis

|May 1, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodialysis.

Clinical nephrology·2009

Lanthanum carbonate (Fosrenol): a novel agent for the treatment of hyperphosphataemia in renal failure and dialysis patients.

International journal of clinical practice·2005

Severe acute renal failure in adults: place of care, incidence and outcomes.

QJM : monthly journal of the Association of Physicians·2005

Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate.

Nephron. Clinical practice·2005

Outcome of pregnancy following renal transplantation.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2004

End-stage renal disease in Indo-Asians in the North-West of England.

QJM : monthly journal of the Association of Physicians·2003

See all related articles